Skip to main content

$0.580 (0%)

High

$0.59

Low

$0.57

Trades

36

Turnover

$59,341

Volume

102,948
30 June 2023 at 3:56pm
Register to track NXS and receive email alerts.
Subject
NXS Ann: Director Retirement

NXS Ann: Market Update

NXS Ann: Appointment of new Managing Director and CEO

NXS Ann: 2023 AGM - Voting Results

NXS Ann: AGM Chair & Managing Director Addresses

NXS Ann: Quarterly Activity Report 31 March 2023 - Addendum

NXS Ann: Corporate Governance Statement and Appendix 4G

NXS Ann: 2023 AGM Notice of Meeting

NXS Ann: 2022 Annual Report

NXS Ann: Investor Presentation - Q1 2023

NXS Ann: Quarterly Activity Report - 31 March 2023

NXS Ann: Appendix 4C - 31 March 2023

NXS Ann: Notification of date of 2023 AGM

NXS Ann: Ceasing to be a substantial holder

NXS Ann: FY22 Investor Presentation

NXS Ann: Next Science FY22 Results and FY23 Outlook

NXS Ann: Appendix 4E / FY22 Financial Statements

NXS Ann: Full Year Results Investor Briefing

NXS Ann: Cleansing notice

NXS Ann: Notification regarding unquoted securities - NXS

NXS Ann: General Meeting - Voting Results

NXS Ann: Proposed issue of securities - NXS

NXS Ann: Cancel - Proposed issue of securities - NXS

NXS Ann: Proposed issue of securities - NXS

NXS Ann: Investor Presentation - Q4 2022

NXS Ann: Appendix 4C - 31 December 2022

NXS Ann: Quarterly Activity Report - 31 December 2022

NXS Ann: Notice of General Meeting

NXS Ann: Next Science secures A$10M convertible notes due 2024

NXS Ann: Change in substantial holding

NXS Ann: Investor Presentation - Q3 2022

NXS Ann: Investor Webinar

NXS Ann: Quarterly Activity Report - 30 September 2022

NXS Ann: Appendix 4C - 30 September 2022

NXS Ann: Next Science US Medicare accreditation signals growth

NXS Ann: Trading Halt

NXS Ann: Pause in Trading

NXS Ann: Next Science's XPERIENCE product cleared for sale in Canada

NXS Ann: Half Year Results Investor Presentation

NXS Ann: Half Year Report & Appendix 4D

NXS Ann: Half Year Results Investor Briefing

NXS Ann: Investor Presentation - Q2 2022

NXS Ann: Quarterly Activity Report - 30 June 2022

NXS Ann: Appendix 4C - 30 June 2022

NXS Ann: Change in substantial holding

NXS Ann: Cleansing notice

NXS Ann: Application for quotation of securities - NXS

NXS Ann: 2022 AGM - Voting Results

NXS Ann: AGM Chair & Managing Director Addresses

NXS Ann: Next Science to strengthen senior leadership presence in US

Register to track NXS and receive email alerts.

Similar Companies

ANN
AVR
MGZ
NAN
OSX
PNV
SDI
SDI